Department of Pharmacology and Toxicology, Virginia Commonwealth University, Medical College of Virginia Campus, Box 980613, Richmond, VA, 23298-0613, USA.
Department of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, Richmond, VA, 23298, USA.
Psychopharmacology (Berl). 2020 Sep;237(9):2777-2793. doi: 10.1007/s00213-020-05572-2. Epub 2020 Jun 11.
Cancer patients receiving the antineoplastic drug paclitaxel report higher incidences and longer duration of treatment-resistant depression than patients receiving other classes of chemotherapeutics. Rodents treated with paclitaxel exhibit a suite of changes in affect-like behaviors. Further, paclitaxel causes chemotherapy-induced peripheral neuropathy (CIPN) in humans and rodents. Kappa opioid receptors (KOR) have a well-established role in depression and neuropathy. The contributions of KOR signaling to paclitaxel-induced aversive-like state and CIPN in rodents remain to be explored.
We aimed to investigate whether dysregulation of the KOR/dynorphin system is associated with paclitaxel-mediated pain-like behavior and depression-like behavior.
Cancer-free male C57BL/6J mice were treated with four injections of vehicle or paclitaxel (32 mg/kg cumulative). The effects of the selective KOR antagonist norbinaltorphimine (norBNI) on paclitaxel-induced sucrose preference deficits and mechanical hypersensitivity were measured. Prodynorphin mRNA and receptor-mediated G protein activation were measured at two time points following the last paclitaxel injection using quantitative real-time polymerase chain reaction and agonist-stimulated [S]guanosine-5'-O'-(γ-thio)-triphosphate ([S]GTPγS) binding, respectively, in the nucleus accumbens (NAc), caudate-putamen, amygdala, and spinal cord.
Paclitaxel produced a norBNI-reversible sucrose preference deficit, whereas mechanical hypersensitivity was not reversed by norBNI. Paclitaxel treatment increased the levels of mRNA for prodynorphin, a precursor for endogenous KOR agonists, in the NAc. Paclitaxel also had time-dependent effects on KOR-mediated G protein activation in the NAc.
These results suggest that KOR signaling mediates an initial aversive component of paclitaxel, but not necessarily paclitaxel-induced mechanical hypersensitivity.
接受抗肿瘤药物紫杉醇治疗的癌症患者报告称,与接受其他化疗药物治疗的患者相比,他们出现治疗抵抗性抑郁的发生率更高、持续时间更长。接受紫杉醇治疗的啮齿动物表现出一系列情感样行为改变。此外,紫杉醇会导致人类和啮齿动物出现化疗引起的周围神经病(CIPN)。κ阿片受体(KOR)在抑郁和神经病中具有明确的作用。KOR 信号转导在紫杉醇引起的啮齿动物厌恶样状态和 CIPN 中的作用仍有待探索。
我们旨在研究 KOR/内啡肽系统的失调是否与紫杉醇介导的疼痛样行为和抑郁样行为有关。
未患癌症的雄性 C57BL/6J 小鼠接受 4 次 vehicle 或紫杉醇(32mg/kg 累积)治疗。测量选择性 KOR 拮抗剂 norbinaltorphimine(norBNI)对紫杉醇引起的蔗糖偏好缺失和机械性超敏反应的影响。使用定量实时聚合酶链反应(qRT-PCR)和激动剂刺激[S]鸟苷-5'-O'-(γ-硫代)三磷酸([S]GTPγS)结合,分别在末次紫杉醇注射后 2 个时间点测量核仁_accumbens(NAc)、尾壳核、杏仁核和脊髓中的原脑啡肽 mRNA 和受体介导的 G 蛋白激活。
紫杉醇产生了 norBNI 可逆转的蔗糖偏好缺失,而机械性超敏反应不能被 norBNI 逆转。紫杉醇治疗增加了 NAc 中内源性 KOR 激动剂前体 prodynorphin 的 mRNA 水平。紫杉醇还对 NAc 中的 KOR 介导的 G 蛋白激活具有时间依赖性影响。
这些结果表明,KOR 信号转导介导了紫杉醇的初始厌恶成分,但不一定介导紫杉醇引起的机械性超敏反应。